Safety and immunogenicity of an MF59®-adjuvanted A/H1N1 pandemic influenza vaccine in children from three to seventeen years of age

出版年份 2015 全文链接

标题

作者

关键词

www.clinicaltrials.gov (NCT00971542), Pandemic influenza, A/H1N1, Vaccine, MF59, Paediatric

出版物

Volume 33, Issue 1, Pages 174-181

出版商

Elsevier BV

发表日期

2014-11-12

DOI

10.1016/j.vaccine.2014.10.085

联系作者

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started